The FTC to Scrutinize the 6 Largest PBMs
The Federal Trade Commission (FTC) has launched an inquiry into the six largest PBMs to scrutinize business practices and the implications they have as prescription drug costs and spending have been on the rise. According to recent research, manufacturer rebates to PBMs increased from $39.7 billion in 2012 to $89.5 billion in 2016 which has …